Sleep Disorder market to witness Massive Growth during the forecast period | Global key players includes GlaxoSmithKline plc, Becton Dickson and Company, Cardinal Health, Natus Medical Incorporated Takeda Pharmaceutical Company Limited, Koninklijke Philip

Market Study Report Add New 2018-2026 Global Sleep Disorder Market Report to its research database presenting an informative study covering the market with detailed analysis. The Sleep Disorder market research report is a professional and in-depth study on the current state of global Industry.

Sleep is complex neurological state that helps in restoring energy level in the body. Alterations in the quality and pattern if sleep may cause sleep disorder. Sleep disorder is defined as a sleep problem, which is characterized by snoring, insomnia, depression, and sleep apnea. Recently, in a study it is found that the approximately more than 75% of Americans from the age of 25 to 59 suffer from sleep disorder in the U.S. Sleep disorder is basically characterize by the difficulty in falling asleep, daytime fatigue, lack of concentration, anxiety, and depression.

Request a sample of this report titled at: https://www.marketstudyreport.com/request-a-sample/1695306/

The sleep disorder market size is anticipated to reach over USD 1.31 billion by 2017. In 2017, the sleep apnea devices dominated the global market, in terms of revenue. Asia-Pacific is expected to be the Fastest growing contributor to the global market revenue in 2017.

The sleep disorder market is primarily driven by the increasing number individual population suffering from various mental disorders, and rising awareness for the treatment of sleep disorders in the coming years. Furthermore, the changing life style of the people, and rising preference to the sedentary life style to also support the market growth in the coming years. Additionally, changing working culture, increasing geriatric population, and lack of quality sleep to also boost the market growth during the forecast period.

On the other side, increasing morbidity due to sleep disorder has increased the healthcare cost, and related side effects of the drugs, and increasing patent expiries that are used in treating sleep disorders which would impede the market growth during the forecast period. The treatment for include medication, better sleeping habits, and devices. Medicines such as, Hetlioz (tasimelteon) by Vanda Pharmaceuticals, Intermezzo (zolpidem tartrate sublingual tablet) by Transcept Pharmaceuticals, and Silenor (doxepin) by Somaxon Pharma are some of the FDA approved drugs that are observed to be beneficial during the treatment of sleep disorders.

Asia Pacific is estimated to be the fastest growing region in terms of revenue. Growing awareness about sleep disorders and developing healthcare infrastructure are some of the factors that are projected to generate lucrative opportunities for the market in APAC.

The industry is segmented on the basis of disorder type, device, treatment, and geography. Based on disorder type, the market is bifurcated into sleep apnea, sleep breathing disorders, insomnia, hypersomnia, circadian rhythm disorders, parasomnia, and sleep movement disorders. on the basis of devices, the market is segmented into sleep apnea devices, sleep laboratories, and mattresses & pillows. By Treatment, the market is further bifurcated as psychiatric treatment, behavioral treatment, cognitive behavioral therapy, and medication therapy.

Request a discount on standard prices of this premium report titled at: https://www.marketstudyreport.com/check-for-discount/1695306/

The market for sleep disorder in North America generated the highest revenue in 2017, and is expected to be the leading region globally during the forecast period. High number of patient population suffering the sleeping disorders is the primary factor accountable for the highest market growth. According to the US Department of Health and Human Services reports, approximately 20% Americans are suffering from sleep disorder. Thus, increasing demand for early treatments along with increasing patient pool, and growing patient awareness for proper diagnosis methods are factors boosting the growth in North America.

The major key players operating in the Sleep Disorder industry include GlaxoSmithKline plc, Becton Dickson and Company, Cardinal Health, Natus Medical Incorporated Takeda Pharmaceutical Company Limited, Koninklijke Philips N.V., and Teva Pharmaceutical Industries Ltd. These companies launch new products and collaborate with other market leaders to innovate and launch new products to meet the increasing needs and requirements of consumers.

Table of Contents:

1. Overview and Scope
1.1. Research goal & scope
1.2. Research assumptions
1.3. Research Methodology
1.4. Key take-away
1.5. Stakeholders
2. Executive Summary
2.1. Market Definition
2.2. Market Segmentation
3. Sleep Disorder Market Insights
3.1. Sleep Disorder Industry snapshot
3.2. Sleep Disorder - Ecosystem analysis
3.3. Sleep Disorder Market Dynamics
3.4. Industry analysis - Porter's five force
3.5. Sleep Disorder Market PEST Analysis
3.6. Sleep Disorder Market Value Chain Analysis
3.7. Sleep Disorder Industry Trends
3.8. Competitive Ranking Analysis, 2017
4. Sleep Disorder Market Size and Forecast by Disorder, 2018-2026
5. Sleep Disorder Market Size and Forecast by Device, 2018-2026
6. Sleep Disorder Market Size and Forecast by Treatment, 2018-2026
7. Sleep Disorder Market Size and Forecast by Region, 2018-2026
8. Company Profiles

Complete report titled at: https://www.marketstudyreport.com/reports/sleep-disorder-market-share-size-trends-industry-analysis-report-by-disorder-insomnia-hypersomnia-sleep-apnea-sleep-breathing-disorders-circadian-rhythm-disorders-parasomnia-sleep-movement-disorders-by-device-by-treatment-by-region-segment-forecast-2018-2026

Related Report:

Global Circadian Rhythm Sleep Disorder Market Size, Status and Forecast 2019-2025

Circadian rhythm sleep disorders are a family of sleep disorders affecting the timing of sleep. The increase in Circadian Rhythm Sleep Disorder Market innovation aids humans in controlling their diet as well as lack of sleep in a systematic manner to stay fit, and fight day to day life obstacles. In 2018, the global Circadian Rhythm Sleep Disorder market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

https://www.marketstudyreport.com/reports/global-circadian-rhythm-sleep-disorder-market-size-status-and-forecast-2019-2025

About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:
Market Study Report LLC
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com
Website: https://www.marketstudyreport.com
Blog: https://www.marketstudyreport.com/blog

This release was published on openPR.